Generic Prescription Drugs


Perrigo Profits, Sales Rise

The generic pharmaceutical and store-brand helath products maker Perrigo Co. (NYSE: PRGO) Thursday reported net income of $111.4 million or $1.18 a share in the first fiscal quarter ended Sept. 28, up from $105.6 million or $1.12 a share in the first fiscal quarter a year earlier. Revenue was $933.4 million, up from $769.8 million a year earlier.

WWJ Newsradio 950–10/31/2013


Perrigo Announces Quarterly Dividend

Perrigo Co. (Nasdaq: PRGO) Thursday announced that its board of directors declared a quarterly dividend of 9 cents a share.

WWJ Newsradio 950–01/31/2013


Perrigo Reports Record Quarterly Revenue, Profit

The generic drug and health and beauty product manufacturer Perrigo Co. Tuesday reported record revenue and profit for the second fiscal quarter ended Dec. 31.

WWJ Newsradio 950–02/07/2012


Perrigo Reports Record Revenue, Profit For Fiscal Year

Allegan-based Perrigo Co. reported record revenue of $2.76 billion for its fiscal year ended June 25, up 21 percent or $487 million from $2.27 billion a year earlier.

WWJ Newsradio 950–08/16/2011